Physician profile
Tamara Stojanovic
NPI 1447243183
$8,537.83
in general payments reported to CMS, 2019-2025
11 companies · $55.11 in 2025
The $55.11 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.60 · 2020: $157 · 2021: $88.46 · 2022: $1,835 · 2023: $6,182 · 2024: $178 · 2025: $55.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $414.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,764.36 | 2022-2023 | Da Vinci Surgical System, Da Vinci Sp |
| Glaxosmithkline, LLC. | $371.75 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $178.45 | 2022 | |
| United Therapeutics Corporation | $64.37 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.28 | 2022-2025 | Jascayd |
| Astrazeneca Pharmaceuticals LP | $32.03 | 2021-2022 | |
| Inspire Medical Systems, INC. | $26.80 | 2025 | Inspire |
| Abiomed | $20.40 | 2024 | Impella |
| Livanova USA, INC. | $14.13 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.26 | 2024 | |
| Inogen, INC. | $4.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Stojanovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.